DCI Blog


Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Patierno Named To Receive 2019 AACR Cancer Health Disparities Award

The American Association for Cancer Research (AACR) has announced Steven R. Patierno, PhD, as the recipient of the 2019 AACR Distinguished Lectureship on the Science of Cancer Health Disparities. Patierno will present his award lecture in San Francisco on Sept. 20 at the 12th AACR Conference on The...

Randles Preps Cancer Simulations for 2021

Randles' team is one of 15 investigator-led teams being given priority to run their world-changing projects on the nation's first exascale computer — the U.S. Department of Energy's “Aurora” — when it debuts in 2021. Randles' simulations could shed light on the mechanisms driving cancer metastasis.

Ginsburg Joins Brotman Baty Institute For Precision Medicine Board

Geoffrey Ginsburg , MD, PhD, the director of the Duke Center for Applied Genomics & Precision Medicine and a Duke Cancer Institute member, has joined the inaugural Scientific Advisory Board of the Brotman Baty Institute for Precision Medicine (BBI) . Ginsburg is one of five leaders in genomics...

DCI Scientific Retreat (10.25.19)

The 6th Annual Duke Cancer Institute Scientific Retreat will be held on Friday, Oct. 25, from 10 a.m. to 6 p.m. at Bay 7 in the American Tobacco Historic District in Durham. The O. Michael Colvin Memorial Lecture will be delivered by Charles M. Perou , PhD, co-director of the Computational Medicine...

Science of Metabolism Provides Insight on Using a Nutrient to Slow Cancer

A team of Duke Health researchers is looking to change that. Using the science of metabolism in laboratory, animal and human experiments, the researchers are exploring how nutrients and chemicals in food navigate the same molecular pathways used by certain cancer therapies to slow tumor growth.

Cost of Breast Cancer Surgery Influences Many Women’s Treatment

Even among well-educated women with health insurance coverage, a significant proportion said the costs of cancer treatment influenced the type of surgery they chose for breast cancer treatment, a study led by the Duke Cancer Institute found. The finding, published online in the Journal of Oncology...

Secord Awarded $1 Million

Angeles Secord, MD, MHSc, has been awarded a $1 million grant funded by the 2019 Kay Yow Cancer Fund and The V Foundation For Cancer Research to support the project, “Endometrial Cancer Molecularly Targeted Therapy Consortium.” The award will be paid in annual installments of $250,000 over the four...

Dorry Receives $25,000 From Lung Cancer Initiative

Michael Dorry , MD, Duke Cancer Institute, is one of five 2019-2020 recipients of the Lung Cancer Initiative Research Grant. Grantees receive $25,000 and are selected based on the measurable impact of their proposal and commitment to the lung cancer field. “We are pleased to support Dr. Dorry and...

Enzalutamide Significantly Improves Progression-Free Survival in Men with Metastatic Prostate Cancer

A multi-institutional group of clinical researchers, led by Duke Cancer Institute’s Andrew Armstrong, MD, MSc, FACP, published a new report this month in the Journal of Clinical Oncology (JCO) that describes results from the ARCHES study. ARCHES prospectively studied and evaluated the efficacy and...

New E-Cigarette Laws Could Drive Some Users to Smoke More Cigarettes

Efforts by the FDA and some cities to limit the availability and appeal of e-cigarettes to young users could drive some existing users to smoke more tobacco cigarettes to get their fix, according to new research from Duke Health. The findings, from a survey of 240 young U.S. adults who use both e-...

With Robust Molecular Tumor Registry "MrT," The Stars Align

With Robust Molecular Tumor Registry, The Stars Align: New MrT database allows the Molecular Tumor Board to analyze genomic testing results from the past five years and send “real-time” alerts to physicians when new treatment options becomes available for their patients.

Researchers Identify Enzyme That Suppresses Immune System in Breast Cancer

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a small number of patients are even eligible to undergo treatment with immunotherapies, and most see little benefit. But in a pre-...